The federal contract award HHSN272201500183P is for the supply of 26 units of O+ human red blood cells at $255.00 per unit, for a total ceiling value of $7,020.00. The contract was awarded on December 15, 2014 to Grifols Bio Supplies Inc., a for-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services. The contract is a firm-fixed-price purchase order with no set-aside designation. The contract is for...
This federal contract award is for the provision of O+ leuko-reduced ACD packed red blood cells to the National Institute of Allergy and Infectious Diseases, a civilian agency under the Department of Health and Human Services. The $14,994.00 firm-fixed-price purchase order was awarded to Grifols Bio Supplies Inc., a for-profit organization, on November 25, 2024. The contract has an ultimate completion date of June 30, 2025 and does not utilize any set-aside designations. The contract supports...
This federal contract award to Grifols Bio Supplies Inc. is for the delivery of 13 units of O+ human packed red blood cells. The $3,640.00 firm-fixed-price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). The contract does not utilize a set-aside and has a completion date of May 1, 2015. Grifols Bio Supplies Inc. is a for-profit organization focused on providing blood products and related services to federal...
This firm-fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) to Grifols Bio Supplies Inc. for the provision of O+ Human Red Blood Cells (RBC) in CPD units. The contract has a ceiling value of $6,760.00 and a period of performance through December 17, 2014. The contract does not have a set-aside designation. Grifols Bio Supplies Inc. is a for-profit organization registered to receive federal contracts, and this award supports medical research and healthcare...
This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) to Grifols Bio Supplies Inc. for the provision of 34 units of O+ human packed red blood cells at a unit price of $255.00, resulting in a total ceiling value of $9,180.00. The contract has no set-aside designation and the work is to be completed by July 6, 2015. Grifols Bio Supplies Inc. is a for-profit organization focused on providing blood products and related services to federal agencies,...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Grifols Bio Supplies Inc. for the provision of 26 units of O+ red blood cells. The contract has a total ceiling value of $6,745.00 and was awarded on October 31, 2013 with a completion date of November 14, 2013. The contract does not have a set-aside designation. Grifols Bio Supplies Inc. is a for-profit...
This contract award HHSN272201500454P is for the supply of O+ human packed red blood cells to the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the Department of Health and Human Services (HHS). The $3,510.00 firm-fixed-price purchase order was awarded to Grifols Bio Supplies Inc., a for-profit business focused on providing blood products and related services to federal agencies. The contract has a period of performance through September 17, 2015 and does not...
This is a $23,760.00 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Grifols Bio Supplies Inc. for the delivery of 100 units of O+ blood. The contract has an ultimate completion date of January 15, 2015 and does not utilize a set-aside designation. The award is part of NIAID's efforts to procure blood products to support medical research and healthcare operations within...
<p>This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Blood Components, Inc. for the provision of 52 units of O+ human red blood cells in CPD at a unit price of $260.00, resulting in a total ceiling value of $14,300.00. The contract has no set-aside designation and a final completion date of May 17, 2017. No further details about a larger contract vehicle or subcontractors are provided.</p>
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $15,876.00 firm fixed-price purchase order contract to Grifols Bio Supplies Inc., a for-profit medical supplies company based in Los Angeles, CA. The contract is for the delivery of 36 units of O+ leuko-reduced ACD human packed red blood cells (RBCs) with varying quantities. This is not a set-aside contract. The contract has an ultimate completion date of December 31, 2025. Grifols Bio Supplies Inc. has an established...